Dual antiplatelet therapy for 1 month following a transient ischaemic attack is associated with a low risk of stroke recurrence and a low incidence of adverse events at 30 days

No Thumbnail Available
Issue Date
2009
Our author(s)
Ellis, A.
Guyler, P.
O'Brien, A.
Department
Keywords
Language
English
Publisher
Karger Publishers
ISSN
1015-9770
eISSN
ISBN
Type
Conference paper
Citation
Kar, A., Ellis, A., Guyler, P. C. & O'Brien, A. O. 2009. Dual antiplatelet therapy for 1 month following a transient ischaemic attack is associated with a low risk of stroke recurrence and a low incidence of adverse events at 30 days. Cerebrovascular Diseases, 27, (SUPPL. 6) 70.
Pubmed ID
URL
Description